GLP-1 agonists like semaglutide can lead to significant weight loss for some, based on genetic profile. Results vary individually, not everyone responds as expected.
Machine learning identified 'hungry gut' phenotype linked to greater weight loss with semaglutide treatment. Genetic analysis can predict patient response, impacting treatment efficacy.
[
add
]
[
|
|
...
]